Concepedia

Author

Mark E. Olah

National Institute of Diabetes and Digestive and Kidney DiseasesORCID

Also Known As

M E Olah, M OLAH, M Oláh, M. E. OLAH, M. Oláh, M.E. Olah, Mark E Olah, Mark E. Olah, Mark Olah, Mark Oláh

86

Publications

4.7K

Citations

29

H-Index

46

Concepts

All Affiliations

National Institute of Diabetes and Digestive and Kidney DiseasesDuke Medical CenterNational Institutes of HealthSemmelweis UniversityDuke University Hospital
ME

About

Mark E. Olah is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

2K

2

Natural Sciences

4

4

930

3

Education

1

1

20

4

Health Sciences

1

1

22

5

Public Health

1

1

20

Mark E. Olah

×

43

Publications

3.9K

Citations

27

H-Index

YearCitations

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Qun Zhou, Chuanfu Li, Mark E. Olah,

Proceedings of the National Academy of Sciences

1992

652

Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors

Jöelle Hillion, Meritxell Canals, Maria Torvinen,

Journal of Biological Chemistry

2002

494

Structure-Activity Relationships of N6-Benzyladenosine-5'-uronamides as A3-Selective Adenosine Agonists

Carola Gallo‐Rodriguez, Xiao-duo Ji, Neli Melman,

Journal of Medicinal Chemistry

1994

238

2-Substitution of N6-Benzyladenosine-5'-uronamides Enhances Selectivity for A3 Adenosine Receptors

Hea O. Kim, Xiao-duo Ji, Suhaib M. Siddiqi,

Journal of Medicinal Chemistry

1994

204

125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Mark E. Olah, Carola Gallo‐Rodriguez, Kenneth A. Jacobson,

Molecular Pharmacology

1994

179

A binding site model and structure-activity relationships for the rat A3 adenosine receptor.

P J van Galen, Anna Bergen, Carola Gallo‐Rodriguez,

Molecular Pharmacology

1994

178

Pharmacological characterization of novel A3 adenosine receptor-selective antagonists

Kenneth A. Jacobson, Kyung Park, Ji-long Jiang,

Neuropharmacology

1997

155

Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.

Mark E. Olah, Hong Ren, Jerzy Ostrowski,

Journal of Biological Chemistry

1992

148

Distinct Pathways of Desensitization of A1- and A2-Adenosine Receptors in DDT1 MF-2 Cells

Vickram Ramkumar, Mark E. Olah, Kenneth A. Jacobson,

Molecular Pharmacology

1991

131

A3-adenosine receptors: Design of selective ligands and therapeutic prospects

Kenneth A. Jacobson, Hea O Kim, Suhaib M. Siddiqi,

Drugs of the Future

1995

126

Page 1